Stiffness Measurement of Liver Tumors and Visceral Parenchyma
NCT ID: NCT01343212
Last Updated: 2011-05-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
50 participants
OBSERVATIONAL
2011-03-31
2012-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Visceral Stiffness Measurement Using Acoustic Radiation Force Impulse
NCT01311934
Acoustic Radiation Force Impulse (ARFI)Technology in Prediction of Liver Fibrosis
NCT01268865
Acoustic Radiation Force Impulse-Imaging in Comparison to Transient Elastography for Liver Fibrosis Staging in HCV
NCT01113814
Determination of Liver Stiffness in Chronic Liver Disease Patients by Acoustic Radiation Force Imaging (ARFI) Ultrasound
NCT02652221
Acoustic Radiation Force Impulse Imaging (ARFI) : a New Technique to Assess Liver Elasticity
NCT01082419
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
newly diagnosed HCC
* Subjects with newly diagnosed untreated hepatocellular carcinoma (HCC) will be enrolled.
* Subjects with the following conditions will be excluded:
liver cancer other than HCC, treated HCC, post major abdominal surgery, contraindications to liver tumor biopsy, contraindications to local percutaneous treatment of liver tumors, low quality ARFI measurement
stiffness measurement using ARFI
Stiffness measurement will be performed for HCC using ARFI technique.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
stiffness measurement using ARFI
Stiffness measurement will be performed for HCC using ARFI technique.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* subjects with treated HCC
* post major abdominal surgery
* contraindications to liver tumor biopsy
* contraindications to local percutaneous treatment of liver tumors
* ARFI measurement low quality
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
China Medical University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
China Medical University Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sheng-Hung Chen, MD
Role: PRINCIPAL_INVESTIGATOR
Hepatogastroenterology, Department of Internal Medicine, China Medical University Hospital
Cheng-Yuan Peng, MD,PhD
Role: STUDY_DIRECTOR
Hepatogastroenterology, Department of Internal Medicine, China Medical University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hepatogastroenterology, Department of Internal Medicine, China Medical University Hospital
Taichung, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DMR100-IRB-055
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.